318 related articles for article (PubMed ID: 16797991)
1. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
Cordato DJ; Schwartz R; Abbott E; Saunders R; Morfis L
J Clin Neurosci; 2006 Jul; 13(6):655-8. PubMed ID: 16797991
[TBL] [Abstract][Full Text] [Related]
2. Burden of illness in Parkinson's disease.
Huse DM; Schulman K; Orsini L; Castelli-Haley J; Kennedy S; Lenhart G
Mov Disord; 2005 Nov; 20(11):1449-54. PubMed ID: 16007641
[TBL] [Abstract][Full Text] [Related]
3. Direct medical costs associated with Parkinson's disease: a population-based study.
Leibson CL; Long KH; Maraganore DM; Bower JH; Ransom JE; O'Brien PC; Rocca WA
Mov Disord; 2006 Nov; 21(11):1864-71. PubMed ID: 16977632
[TBL] [Abstract][Full Text] [Related]
4. [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].
Cubo E; Martínez Martin P; González M; Frades B;
Neurologia; 2009; 24(1):15-23. PubMed ID: 19003550
[TBL] [Abstract][Full Text] [Related]
5. Resource use and costs in a Swedish cohort of patients with Parkinson's disease.
Hagell P; Nordling S; Reimer J; Grabowski M; Persson U
Mov Disord; 2002 Nov; 17(6):1213-20. PubMed ID: 12465059
[TBL] [Abstract][Full Text] [Related]
6. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.
Dhawan V; Dhoat S; Williams AJ; Dimarco A; Pal S; Forbes A; Tobías A; Martinez-Martin P; Chaudhuri KR
J Neurol Sci; 2006 Oct; 248(1-2):158-62. PubMed ID: 16780888
[TBL] [Abstract][Full Text] [Related]
7. The economic implications of treating atherothrombotic disease in Australia, from the government perspective.
Ademi Z; Liew D; Hollingsworth B; Wolfe R; Steg GP; Bhatt DL; Reid CM;
Clin Ther; 2010 Jan; 32(1):119-32; discussion 106-7. PubMed ID: 20171418
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.
Wang G; Cheng Q; Zheng R; Tan YY; Sun XK; Zhou HY; Ye XL; Wang Y; Wang Z; Sun BM; Chen SD
Mov Disord; 2006 Sep; 21(9):1439-43. PubMed ID: 16773620
[TBL] [Abstract][Full Text] [Related]
9. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
Noyes K; Liu H; Li Y; Holloway R; Dick AW
Mov Disord; 2006 Mar; 21(3):362-72. PubMed ID: 16211621
[TBL] [Abstract][Full Text] [Related]
10. Costs of drug treatment in Parkinson's disease.
Dodel RC; Eggert KM; Singer MS; Eichhorn TE; Pogarell O; Oertel WH
Mov Disord; 1998 Mar; 13(2):249-54. PubMed ID: 9539337
[TBL] [Abstract][Full Text] [Related]
11. Costs of Parkinson's disease in eastern Europe: a Czech cohort study.
Winter Y; von Campenhausen S; Brozova H; Skoupa J; Reese JP; Bötzel K; Eggert K; Oertel WH; Dodel R; Ruzicka E
Parkinsonism Relat Disord; 2010 Jan; 16(1):51-6. PubMed ID: 19665915
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data.
Davis KL; Edin HM; Allen JK
Mov Disord; 2010 Mar; 25(4):474-80. PubMed ID: 20131374
[TBL] [Abstract][Full Text] [Related]
13. Health care costs associated with posttraumatic stress disorder symptoms in women.
Walker EA; Katon W; Russo J; Ciechanowski P; Newman E; Wagner AW
Arch Gen Psychiatry; 2003 Apr; 60(4):369-74. PubMed ID: 12695314
[TBL] [Abstract][Full Text] [Related]
14. A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis.
Jackson J; Fernandes AW; Nelson W
Clin Ther; 2006 Sep; 28(9):1462-71. PubMed ID: 17062318
[TBL] [Abstract][Full Text] [Related]
15. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
Etzioni R; Ramsey SD; Berry K; Brown M
Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing the cost of hospital care for people with diabetes in Australia.
Clarke P; Kelman C; Colagiuri S
J Diabetes Complications; 2006; 20(6):349-55. PubMed ID: 17070437
[TBL] [Abstract][Full Text] [Related]
17. Cost of dental services provided in private general practice for an insured population in New South Wales, Australia.
Sivaneswaran S; Taylor R; Lazarus R
Community Dent Health; 2000 Dec; 17(4):246-53. PubMed ID: 11191200
[TBL] [Abstract][Full Text] [Related]
18. Trends in resource utilization for Parkinson's disease in Germany.
Winter Y; Balzer-Geldsetzer M; von Campenhausen S; Spottke A; Eggert K; Oertel WH; Dodel R
J Neurol Sci; 2010 Jul; 294(1-2):18-22. PubMed ID: 20493500
[TBL] [Abstract][Full Text] [Related]
19. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
20. Population prevalence and incidence of Parkinson's disease in an Australian community.
Mehta P; Kifley A; Wang JJ; Rochtchina E; Mitchell P; Sue CM
Intern Med J; 2007 Dec; 37(12):812-4. PubMed ID: 17561942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
